Belien P
Centre for the New Europe, Zellik, Belgium.
Pharmacoeconomics. 1996;10 Suppl 2:94-9. doi: 10.2165/00019053-199600102-00015.
The European welfare states are currently struggling with tremendous budget problems. Most debate appears to be concerned with how to cut healthcare costs. Unfortunately, limiting the state's costs, rather than enhancing the people's well-being, has become the prime focus of new healthcare strategies in the European welfare states. The result has been a reduction in the quality and availability of healthcare services and a diminishing contribution to medical innovation by most European countries. Abandonment of the 'pay-as-you-go' financing system is the only solution to increasingly unsustainable welfare state healthcare systems. A system financed by a capitalisation mechanism would be protected from the increasing costs associated with demographic evolution, while providing all members of society with the opportunity for affordable healthcare coverage.
欧洲福利国家目前正面临巨大的预算问题。大多数辩论似乎都集中在如何削减医疗成本上。不幸的是,限制国家成本而非提高人民福祉,已成为欧洲福利国家新医疗战略的首要重点。结果是医疗服务的质量和可及性下降,大多数欧洲国家对医疗创新的贡献也在减少。放弃“现收现付”融资体系是日益不可持续的福利国家医疗体系的唯一解决方案。由资本化机制融资的体系将免受与人口结构变化相关的成本增加的影响,同时为社会所有成员提供获得负担得起的医疗覆盖的机会。